脑机接口
Search documents
坐标中部大省,脑机“超级工厂”落地
Mei Ri Jing Ji Xin Wen· 2026-01-13 15:30
"超级工厂"之所以落地江西,除了当地较低的人力与土地成本、丰富的原材料资源外,也得益于其集成 电路、医疗器械、生物医药等完善的制造业体系——如吉安合力泰(002217)的精密传感器、赣州同兴 达(002845)的嵌入式系统、南昌晶能光电的光电子器件等,为脑机接口设备提供了关键配套支持。 江西地处长江中下游,与长三角地区相邻,是长三角一体化发展的腹地。此前江西就曾提出,要促进更 多科技成果在江西转化落地。最新公布的江西"十五五"规划建议还提出,主动对接和服务长三角一体化 发展,搭建跨区域产业转移合作平台,健全利益共享机制。 以此次脑虎科技"超级工厂"为例,作为"强磁核",其将联动上下游供应链企业,在赣江新区打造覆盖核 心部件、研发服务与临床应用的完整产业矩阵,加速形成具有全球竞争力的脑机接口产业集群。 从地方政策来看,早在2023年,脑机接口就被纳入江西省未来产业规划;2025年11月,《江西省加快脑 机接口技术和产业发展若干措施》出台,提出了11条具体举措,要拥抱这个"超级风口",抢抓未来产业 机遇。 从企业落地来看,江西的布局还可以继续倒推——2019年,国内侵入式脑机接口领域尚处冷门时,时任 中国科学院上 ...
优刻得:脑虎科技是公司多年战略合作伙伴
Zheng Quan Ri Bao Zhi Sheng· 2026-01-13 13:10
证券日报网讯 1月13日,优刻得在互动平台回答投资者提问时表示,脑虎科技既是公司的客户,也是公 司多年来共同成长的战略合作伙伴。自2022年起,优刻得与脑虎科技就建立了战略合作关系,共同推进 脑电数据的云端化处理。2023年,优刻得与脑虎科技、复旦大学附属华山医院共同入选上海市未来产业 脑机接口专家委员会成员单位,充分发挥在云计算、大数据、人工智能领域的先进优势,共同探索脑机 接口技术在医疗康复领域的应用。2024年以来,优刻得与脑虎科技进一步深化合作,共同参与了上海市 脑机接口领域的重大科研项目申报。双方联手研发"植入式言语合成脑机接口产品",旨在帮助失语患者 恢复部分语言功能。目前,借助优刻得的高性能算力与可靠的数据存储能力,脑虎科技已成功搭建了 GPU算力平台和语料数据管理系统。云计算是AI时代重要的基础设施,作为国内领先的中立第三方云 计算服务商,优刻得一方面将智能算力高效、精准地提供给千行百业的企业客户,另一方面充分发挥自 身算力运营优势和技术研发能力,与部分前沿行业的重点客户开展多维度合作,共同探索AI应用场景 和商业闭环路径,努力推动AI解决实际问题、创造经济价值。 (编辑 丛可心) ...
脑机接口走出实验室,强脑科技递表港交所
Bei Jing Shang Bao· 2026-01-13 12:15
Group 1 - Strong Brain Technology has submitted a confidential IPO application to the Hong Kong Stock Exchange, with expectations that its listing is only a matter of time [2] - The company recently completed approximately 2 billion yuan in Pre-IPO financing, achieving a post-investment valuation of over 1.3 billion USD [2] - The global brain-computer interface (BCI) market is experiencing significant growth, with a compound annual growth rate (CAGR) of over 13% from 2019 to 2023, and is projected to reach 7.63 billion USD by 2029 [4] Group 2 - The funds raised from the recent financing will be used to accelerate core technology research and development, extreme engineering breakthroughs, and product scaling [3] - Strong Brain Technology aims to help 1 million physically disabled individuals regain daily life through neural-controlled prosthetics and improve the conditions of 10 million patients suffering from brain-related disorders [3] - The company differentiates itself from competitors like Neuralink by focusing on non-invasive solutions and developing super sensors to detect human neural signals [4] Group 3 - The Chinese government has included brain-computer interfaces in its national strategic planning, indicating a shift from laboratory research to a national priority [4] - The stock market has reacted to the BCI concept, with companies like Innovation Medical and Rock Mountain Technology experiencing consecutive trading gains [4] - Recent inquiries from the Shanghai Stock Exchange regarding partnerships in the BCI space highlight the regulatory scrutiny and market interest surrounding this technology [5]
新型储能纳入政府投资基金投向!国家首次作出系统规范
中关村储能产业技术联盟· 2026-01-13 12:15
Core Viewpoint - The article discusses the implementation of a new regulatory framework for government investment funds in China, aimed at optimizing their layout and guiding investment directions to support national strategies and industrial upgrades [2][3][4]. Group 1: Government Investment Fund Overview - Government investment funds are established by various levels of government to guide social capital in supporting industry development and innovation through market-oriented methods such as equity investment [2][12]. - The new framework includes a systematic approach to fund layout and investment direction, marking the first national-level regulation of government investment funds [2][4]. Group 2: Supported Investment Areas - The framework identifies key investment areas, including: - Emerging and future industries such as information technology, new energy, advanced manufacturing, and artificial intelligence [2][3]. - Upgrading traditional industries and supporting high-quality development in manufacturing [3][4]. - Promoting the digital economy through initiatives like "AI+" and the application of 5G technology [3][4]. Group 3: Policy Measures - The framework outlines 14 policy measures focusing on three main aspects: where to invest, how to invest, and who manages the funds [3][4]. - It emphasizes early, small, long-term investments in hard technology and aims to prevent homogeneous competition and crowding out of social capital [11][12]. Group 4: Evaluation Management - An evaluation management method has been established to assess the investment direction of government funds, focusing on compliance with national planning and industry directories [4][5]. - The evaluation system includes three main indicators: policy compliance (60% weight), optimization of productivity layout (30% weight), and policy execution capability (10% weight) [6][7]. Group 5: Specific Evaluation Indicators - The evaluation indicators cover aspects such as support for new productivity, technology innovation, green development, and the promotion of private investment [29][33]. - Specific metrics include the proportion of investments in encouraged industries, the effectiveness of fund management, and the impact on social welfare [29][33][40].
马斯克科技生态链系列之国内深度绑定解码
Xin Lang Cai Jing· 2026-01-13 11:54
Core Insights - Elon Musk's technological ecosystem is rapidly evolving, integrating six key industries: commercial space (SpaceX), brain-machine interfaces (Neuralink), humanoid robots (Optimus), autonomous driving (FSD), artificial intelligence (X AI), and hyperloop (The Boring Company) [1][19] - The technological advancements and mass production efforts are reshaping the global tech industry landscape and presenting certain investment opportunities for domestic companies in related sectors [1][19] Group 1: Deep Binding from Components to System Integration - The production of Tesla's Optimus robot is set to begin, with a target of 100,000 units by 2026, but the localization rate of core components is still below 30%, leaving significant market penetration opportunities for domestic high-barrier companies [21] - Top Group is a core supplier for Tesla's vehicle chassis and has entered the testing phase for Optimus's rotating joints, showcasing strong system integration capabilities [21] - Greentech Harmonic is a leading global harmonic reducer supplier, with its Y series products passing Tesla's extreme conditions test and set to deliver 10,000 units by 2025 [21] - Sanhua Intelligent Control is leveraging its experience in automotive thermal management to quickly enter the robot electromechanical actuator and thermal management systems market [21] - Mingzhi Electric is one of the few companies capable of mass-producing hollow cup motors, which are critical for achieving human-like dexterity in robotic hands [21] Group 2: L5 Autonomous Driving - Hardware and Software Integration - Tesla's Full Self-Driving (FSD) is accelerating its rollout, with deep participation from the Chinese supply chain in hardware iteration and software adaptation [22] - Desay SV is supplying the autonomous driving domain controller to Tesla's North American supply chain, with FSD-related orders expected to reach 1.2 billion yuan by 2025 [22] - Lianchuang Electronics is the main supplier of vehicle-mounted lenses for Tesla's HW4.0, holding approximately 60% market share [22] - Zhongke Chuangda, as a leading vehicle operating system provider, is continuously optimizing AI model efficiency on Tesla's platform to support smooth FSD software deployment [22] Group 3: Technical Collaboration - Patent Sharing and Capability Building - Some companies, while not supplying on a large scale, are building long-term barriers through technical cooperation [23] - Changying Precision has reached a cross-licensing agreement with Tesla regarding flexible sensors, enhancing its technological moat in robot perception [23] - Sanhua Intelligent Control is jointly developing actuator efficiency optimization solutions to enhance Optimus's operational endurance [24] - Yanshan Technology's pure vision autonomous driving solution aligns closely with FSD technology, currently supporting Tesla indirectly through international Tier 1 suppliers [24] Group 4: Potential Tracks - From Benchmarking to Entry - In commercial space, Chinese companies are gaining certification in key areas as SpaceX's Starlink accelerates deployment [25] - Tongyu Communication has developed a microwifi antenna module that has passed SpaceX interface certification, expected to supply 60% of Starlink's dedicated modules starting Q3 2025 [25] - Xinyi Communication's subsidiary is the exclusive supplier of high-frequency connectors for Starlink ground terminals, with annual revenue projected to exceed 1.5 billion yuan [25] - Blue Arrow Aerospace is the only domestic company mastering reusable liquid oxygen-methane rocket technology, establishing a significant barrier in low-cost, high-frequency launches [25] Group 5: Brain-Machine Interfaces - Complementary Paths for Cooperation - Neuralink focuses on invasive methods, while Chinese companies are exploring non-invasive and clinical translation paths [30] - Yanshan Technology's non-invasive BCI technology complements Neuralink's approach, indicating clear cooperation potential if Neuralink expands into consumer products [30] - Hanwei Technology's subsidiary has developed ultra-flexible sensors that are cost-competitive and have entered the international supply chain [30] - Sanbo Brain Science is the only private hospital in China with clinical implantation qualifications for brain-machine interfaces, performing over 30,000 surgeries annually [30] Group 6: Indirect Competition and Strategic Value - Some companies, while not directly collaborating with Musk's ecosystem, play a crucial role in national projects, fulfilling "domestic substitution" responsibilities [31] - China Satellite and China Satcom are leading the "Star Network Project," competing with Starlink in satellite manufacturing and operations [31] - Cambrian is developing AI chips that meet xAI's computational needs, presenting potential entry points if Tesla or xAI expands their supply chains [32] - Four-dimensional Map has over 60% market share in high-precision mapping, providing core positioning services for Tesla in China [33] Group 7: Selection Logic for "Invisible Champions" - Companies that meet the criteria of "technological leadership, low public recognition, high industry relevance, and sustained innovation barriers" have emerged as key players [34] - Mingzhi Electric is a global leader in hollow cup motors, essential for dexterous robotic hands [34] - Sanhua Intelligent Control is a dual leader in thermal management and actuators, validated by Tesla [34] - Top Group excels in system integration from chassis to joint assembly, showcasing deep binding [34] - Industrial Fulian is the largest server manufacturer globally, benefiting directly from xAI's computational expansion [34] - Blue Arrow Aerospace is the only player in liquid oxygen-methane reusable rockets, shaping the future of China's commercial space industry [34]
强脑科技或已秘密递交香港上市申请,与中金、瑞银合作,有望成“杭州六小龙”首家上市公司
机器人圈· 2026-01-13 09:41
Core Viewpoint - Strong Brain Technology is preparing for an IPO in Hong Kong, potentially raising hundreds of millions of dollars, collaborating with China International Capital Corporation and UBS for the issuance [1][3]. Group 1: Company Overview - Strong Brain Technology is expected to be the first company listed among the "Six Little Dragons of Hangzhou" [2]. - The company recently completed approximately 2 billion yuan in financing, marking the second-largest funding round globally in the brain-computer interface sector, following Neuralink [2]. - The investor lineup includes prominent institutions such as IDG, Huaden International, and major companies like Lens Technology and Lingyi iTech [2]. Group 2: Product and Technology - Strong Brain Technology focuses on breakthroughs in brain-computer interface technology, aiming to establish communication pathways between the brain and external devices to assist individuals with disabilities [3][5]. - The company has received FDA and CE certifications, making it one of the largest investors in brain-computer interface R&D globally [2]. - Its core product, a super sensor, can detect weak signals from the brain without invasive procedures, enabling the development of neuro-controlled prosthetics for individuals with limb disabilities [5]. Group 3: Future Prospects - The company plans to continue its focus on non-invasive brain-computer interfaces, targeting solutions for conditions such as depression and Alzheimer's disease [6]. - Strong Brain Technology aims to help 1 million individuals with limb disabilities regain mobility and assist 10 million patients suffering from brain-related conditions like Alzheimer's and autism over the next 5 to 10 years [5].
哈佛学霸创办的杭州六小龙,要IPO了
Xin Lang Cai Jing· 2026-01-13 09:38
Core Viewpoint - Qiangnao Technology is reportedly preparing for an IPO in Hong Kong, aiming to raise a significant amount of capital, following a recent financing round that set a record in the brain-computer interface sector, second only to Neuralink [1][10]. Company Overview - Qiangnao Technology is recognized as China's first unicorn in the brain-computer interface space, focusing on enabling users to control machines through thought [11][12]. - The company adopts a non-invasive approach, contrasting with Neuralink's invasive method, which involves surgical implantation of chips in the brain [12][22]. Financial Projections - Following a recent financing round, Qiangnao's valuation exceeded $1.3 billion (approximately 9.2 billion RMB), with analysts estimating a potential market capitalization of 100 billion RMB upon IPO, and possibly reaching 200-300 billion RMB under high demand [3][13]. - Revenue projections for 2025 suggest Qiangnao could surpass 800 million RMB, with a net profit of approximately 120 million RMB, indicating a year-on-year growth rate exceeding 100% [3][13]. Founder Background - The founder, Han Bicheng, is a 1987-born entrepreneur from Heilongjiang, who studied at the Korea Advanced Institute of Science and Technology and later pursued a PhD at Harvard University [14][17]. - Han's early experiences in a medical research center influenced his vision of redefining human interaction with technology through brain-computer interfaces [15][18]. Market Position and Competition - Qiangnao Technology and Neuralink are the two highest-funded companies in the global brain-computer interface sector, representing distinct technological paths and commercialization strategies [9][22]. - The company is positioned to potentially become the first among the "Hangzhou Six" to go public, leveraging a shorter review process in Hong Kong compared to A-share listings [21][22]. Vision and Future Outlook - Qiangnao has articulated a vision for brain-computer interface technology to become as transformative as electricity in the modern era, suggesting it could revolutionize various industries once fully developed [22].
杨德龙:2026年市场行情开局良好
Xin Lang Cai Jing· 2026-01-13 09:32
Core Viewpoint - The market in 2026 is expected to continue the trends of 2025, with a more diversified performance across various sectors, moving away from the "barbell" strategy observed in 2025, where low-valuation, high-dividend sectors like banks and high-performing tech stocks dominated [1][10]. Group 1: Market Trends and Investor Behavior - In 2025, the market exhibited a "barbell" characteristic, with significant gains in low-valuation sectors and standout performance in tech stocks, while traditional sectors showed lackluster performance [1][10]. - Many investors did not achieve satisfactory returns in 2025 due to inadequate allocation towards the two main investment themes, leading to lower overall returns and even losses [1][10]. - The strong performance of the market in 2026 is anticipated to enhance investor confidence and improve the overall market sentiment [1][8]. Group 2: Capital Market Dynamics - A significant shift in resident savings is expected, with a large influx of funds into the capital market, driven by declining savings rates and limited investment opportunities in traditional sectors [2][11]. - In 2025, new fund issuance exceeded 1 trillion yuan, primarily in equity funds, marking a notable shift where equity fund sales surpassed fixed-income products for the first time [2][11]. - The number of new stock accounts opened in 2025 reached over 27 million, indicating strong investor interest and engagement in the capital market [2][11]. Group 3: Economic Impact and Consumer Behavior - The capital market's recovery is seen as a crucial mechanism for boosting consumer spending, as families recover from significant wealth losses due to declining real estate values [3][12]. - The market's performance is expected to help stabilize the real estate sector, particularly in core areas of first-tier cities, while many regions still face oversupply issues [3][12]. - The ongoing bull market is viewed as a vital tool for enhancing household financial health and increasing disposable income, thereby stimulating consumption [3][12]. Group 4: Technological Innovation and Investment Opportunities - The strengthening of the stock market is projected to facilitate a resurgence in IPOs, allowing more tech innovation companies to access capital [4][13]. - The focus of the "14th Five-Year Plan" aligns with sectors that performed well in 2025, such as semiconductors and quantum technology, indicating significant opportunities for growth in these areas [4][13]. - The AI technology sector is still in its early stages, with substantial potential for growth as it moves towards large-scale commercialization [5][14]. Group 5: Investment Strategy and Sector Differentiation - Investment in tech stocks in 2026 will require a more differentiated approach, focusing on companies with core technologies and real application potential, as opposed to those that are merely conceptual [6][15]. - The human-robotics sector is expected to shift from a phase of expectation to one of actual order fulfillment, with companies securing contracts from leading manufacturers likely to see greater growth [6][15]. - Other tech sectors are anticipated to follow a similar trajectory, with software companies and data-related enterprises poised for growth as the industry evolves [7][15]. Group 6: Overall Market Sentiment - The market is expected to see an increase in profitability and investor satisfaction, contributing to a sustained recovery in market confidence [8][16].
我国首家超声波脑机接口企业成立
Ke Ji Ri Bao· 2026-01-13 09:01
Core Viewpoint - The establishment of Gestala, China's first ultrasound brain-computer interface company, marks a significant advancement in the field of brain-computer interfaces, focusing on a new route centered on ultrasound technology [1][2]. Group 1: Company Overview - Gestala was co-founded by Peng Lei, former CEO of Brain Tiger Technology, and Chen Tianqiao, founder of Shanda Group and Tianqiao Brain Science Research Institute [1]. - The company is based in Chengdu and aims to explore next-generation platforms for reading and writing brain signals [1]. Group 2: Technology and Innovation - Ultrasound brain-computer interface technology addresses traditional challenges in brain science research, particularly the difficulties in achieving both "whole-brain imaging" and "real-time response" [1]. - Unlike invasive electrodes and functional MRI (fMRI) that have delays of 3-10 seconds, ultrasound technology allows for non-invasive, precise modulation of specific brain areas and high temporal and spatial resolution recording of blood flow signals in different brain regions [1]. Group 3: Collaborations and Future Plans - Gestala has established collaborative frameworks with Huashan Hospital, Xiehe Hospital, and West China Hospital, aiming to deepen industry-academia-research-medical cooperation for clinical studies on various indications [1]. - The company plans to leverage China's advantages, such as policy support, abundant talent, low clinical costs, large patient scale, and a complete industrial chain, to potentially achieve a competitive edge in the ultrasound brain-computer interface field [2].
资金和政策协同发力 脑机接口技术落地与商业化提速并进
Sou Hu Cai Jing· 2026-01-13 08:38
Core Insights - The article discusses the rapid advancement and commercialization of brain-computer interface (BCI) technology in China, driven by policy support and significant capital investment [1][5][9]. Technological Breakthroughs - Recent breakthroughs in BCI technology include successful clinical trials for invasive systems, enabling high-level paraplegic patients to control devices like smart wheelchairs and robotic dogs [5][6]. - Companies like JieTi Medical and ChipSmart have made significant progress, with JieTi completing three invasive clinical trials and ChipSmart's semi-invasive product achieving successful human implants [5][6]. - The BCI technology is categorized into non-invasive, semi-invasive, and invasive types, each with its advantages and disadvantages [5]. Policy and Capital Support - The Chinese government has identified BCI as one of the six future industries in the 14th Five-Year Plan, providing a strategic framework for its development [8][9]. - Recent policy initiatives include the establishment of independent billing for BCI services by the National Medical Insurance Administration, with several provinces setting clear pricing for BCI medical services [8][9]. - The National Medical Products Administration has also initiated standards for BCI technology, which will help reduce costs and risks associated with clinical applications [8][9]. Market Opportunities - The BCI market is expected to grow significantly, with a focus on medical applications for conditions like stroke, epilepsy, and paralysis, where patients show a strong willingness to adopt early products [6][7]. - The integration of BCI technology with artificial intelligence and robotics could open up a trillion-dollar market space in the long term [11]. Industry Standardization - The BCI industry is anticipated to move towards standardization and scalability, with initial industry standards expected to be established by 2027-2028 [10]. - The domestic BCI industry benefits from strong policy support, a vast clinical resource base, and a complete supply chain, which are crucial for its growth [10]. Investment Landscape - Investment firms highlight the dual nature of BCI as both a medical and technology investment, emphasizing the importance of identifying policy-supported "true BCI" targets [11]. - The potential for leading Chinese BCI companies to emerge on the global stage is significant, given the country's advancements in technology and supportive investment environment [11].